Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire?
Open Access
- 6 November 2009
- journal article
- editorial
- Published by Springer Nature in Diabetologia
- Vol. 53 (1), 1-6
- https://doi.org/10.1007/s00125-009-1591-5
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Pancreatic duct replication is increased with obesity and type 2 diabetes in humansDiabetologia, 2009
- Cell death and tissue remodeling in planarian regenerationDevelopmental Biology, 2009
- Glucagon-Like Peptide-1 Receptor Activation Modulates Pancreatitis-Associated Gene Expression But Does Not Modify the Susceptibility to Experimental Pancreatitis in MiceDiabetes, 2009
- Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)The Lancet, 2009
- New Insights Into the Mechanisms of PancreatitisGastroenterology, 2009
- Beneficial Endocrine but Adverse Exocrine Effects of Sitagliptin in the Human Islet Amyloid Polypeptide Transgenic Rat Model of Type 2 DiabetesDiabetes, 2009
- Increased Risk of Acute Pancreatitis and Biliary Disease Observed in Patients With Type 2 DiabetesDiabetes Care, 2009
- Past medical conditions and K-ras mutations in pancreatic ductal adenocarcinoma: a hypothesis-generating studyCancer Causes & Control, 2008
- Stabilization of β-Catenin Induces Pancreas Tumor FormationGastroenterology, 2008
- Wnt signaling regulates pancreatic β cell proliferationProceedings of the National Academy of Sciences, 2007